Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

NCT: NCT06003036 · RECRUITING

NCT IDNCT06003036
StatusRECRUITING
Start Date2023-12-01
Completion2026-07

Brief Summary

In this study, the investigators will examine whether a type of repetitive transcranial magnetic stimulation called accelerated intermittent theta burst stimulation (iTBS) can augment neurocognition in individuals who receive treatment with clozapine. Following a baseline evaluation and magnetic resonance imaging (MRI), participants will undergo a session of iTBS +MRI and session of sham delivery + MRI. The order for these sessions will be blinded and randomized. The investigators predict that accelerated iTBS will enhance neurocognition relative to sham delivery.

Frequently Asked Questions

What is Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine?

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine is a clinical trial registered under NCT06003036. Current status: RECRUITING.

What is the status of NCT06003036?

The current status of NCT06003036 (Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine) is: RECRUITING.

When did Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine start?

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine started on 2023-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑